Skip to Main Content

Paper Details

Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.
Genet Med
12
2016
395 sequence variants, PharmGKB 1A and 1B variants, Pharmacogenomics, SNP chip, UDP, Undiagnosed Diseases, annotated sequence variants, exome sequence, participants, patient, pharmacogenetic variants, single-nucleotide polymorphism (SNP) chip
Author NameAffiliation
Elizabeth LeeNational Institutes of Health
Elizabeth LeeNational Human Genome Research Institute, National Institutes of Health
Karen XuNational Institutes of Health
Karen XuNational Human Genome Research Institute, National Institutes of Health
Amanda E LinksNational Institutes of Health
Amanda E LinksNational Human Genome Research Institute, National Institutes of Health
Jessica Guzm??n-MoralesNational Institutes of Health
Jessica Guzm??n-MoralesNational Human Genome Research Institute, National Institutes of Health
David R AdamsNational Institutes of Health
David R AdamsNational Human Genome Research Institute, National Institutes of Health
David R AdamsNational Institutes of Health
David R AdamsNational Human Genome Research Institute, National Institutes of Health
Elise FlynnNational Institutes of Health
Elise FlynnNational Human Genome Research Institute, National Institutes of Health
Elise ValkanasNational Institutes of Health
Elise ValkanasNational Human Genome Research Institute, National Institutes of Health
Camilo ToroNational Institutes of Health
Camilo ToroNational Human Genome Research Institute, National Institutes of Health
Cynthia J TifftNational Institutes of Health
Cynthia J TifftNational Human Genome Research Institute, National Institutes of Health
Cynthia J TifftNational Institutes of Health
Cynthia J TifftNational Human Genome Research Institute, National Institutes of Health
Cornelius F BoerkoelNational Institutes of Health
Cornelius F BoerkoelNational Human Genome Research Institute, National Institutes of Health
Cornelius F BoerkoelNational Institutes of Health
Cornelius F BoerkoelNational Human Genome Research Institute, National Institutes of Health
William A GahlNational Institutes of Health
William A GahlNational Human Genome Research Institute, National Institutes of Health
William A GahlNational Institutes of Health
William A GahlNational Human Genome Research Institute, National Institutes of Health
Murat SincanNational Institutes of Health
Murat SincanNational Human Genome Research Institute, National Institutes of Health
  • 1 - 32

Datasets

PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink